93587 ⎘
Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
Amino Acid-Containing Ionizable Lipids for the Delivery of Therapeutic Agents
#2Sulfur-Containing Ionizable Lipids for the Delivery of Therapeutic Agents
#3Sulfur-Containing Ionizable Lipids for the Delivery of Therapeutic Agents
#4Sulfur-containing Compounds and Compositions Thereof for Delivery of Nucleic Acids
#5IONIZABLE LIPID CONTAINING BIODEGRADABLE DISULFIDE BOND AND LIPID NANOPARTICLES COMPRISING SAME
#6EFFECTIVE MEANS TO MODULATE NMDA RECEPTOR-MEDIATED TOXICITY
#7FUNCTIONALIZED BISAMINOTHIOL DERIVATIVES, COMPLEXES WITH THESE BISAMINOTHIOL DERIVATIVES AND USE OF SAID COMPLEXES AS DIAGNOSTICS AND THERAPEUTICS
#8Sulfur-Containing Lipids
#9METHOD OF SYNTHESIS OF AN IONIZABLE CATIONIC LIPID
#10VITAMIN CATIONIC LIPIDS
#11CATIONIC LIPID HAVING DISULFIDE BOND, LIPID MEMBRANE STRUCTURE INCLUDING SAME, NUCLEIC ACID INTRODUCTION AGENT AND PHARMACEUTICAL COMPOSITION CONTAINING ANY ONE OF SAME, METHOD FOR INTRODUCING NUCLEIC ACID INTO CELL OR TARGET CELL, AND METHOD FOR PRODUCING CELLULAR PHARMACEUTICAL
#12Lyophilized Pharmaceutical Compositions Comprising A Lipid Nanoparticle
#13Methods for Detecting Renal Disease
#14ANALOGS AND CONJUGATES OF ß-AMINOISOBUTYRIC ACID (BAIB)
#15MULTICOMPONENT DEGRADABLE CATIONIC POLYMERS
#16NITROPHENYL-ACRYLAMIDES AND USES THEREOF
#17ELECTROLYTE ADDITIVES FOR ZINC BATTERIES
#18NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#19SULFINYLAMINOBENZAMIDE AND SULFONYLAMINOBENZAMIDE DERIVATIVES
#20Lyophilized Pharmaceutical Compositions Comprising a Lipid Nanoparticle
#21SULFUR-CONTAINING IONIZABLE LIPIDS FOR THE DELIVERY OF NUCLEIC ACIDS AND OTHER THERAPEUTIC AGENTS
#22NOVEL CATIONIC LIPID EXHIBITING IMPROVED INTRACELLULAR DYNAMICS
#23SULFIDE-BASED COMPOUNDS AND USES THEREOF
#24Sulfur-containing ionizable lipids for the delivery of nucleic acids and other therapeutic agents
#25(HETERO)ARYLAMIDE COMPOUND AND PEST CONTROL AGENT
#26Compounds and Methods for Use in Detecting Gabapentin
#27COMPOUNDS WITH CLEAVABLE DISULFIDE MOIETIES
#28SULFUR-CONTAINING LIPIDS
#29IONIZABLE LIPIDS AND COMPOSITIONS FOR NUCLEIC ACID DELIVERY
#30Lipids and compositions for the delivery of therapeutics
#31NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#32Ionizable lipids and compositions for nucleic acid delivery
#33Alkoxy compounds for disease treatment
#34PROCESS FOR THE PREPARATION OF CYSTEAMINE BITARTRATE AND PRODUCT SO OBTAINED
#35RADIO-AND CHEMO-PROTECTIVE COMPOUNDS
#36LIPID CONTAINING FORMULATIONS
#37Lipid compound as well as lipid carrier, nucleic acid lipid nanoparticle composition and pharmaceutical preparation containing same
#38Substituted bicyclic compounds
#39Compounds and methods for use in detecting gabapentin
#40USE OF AMINOTHIOL COMPOUNDS AS CEREBRAL NERVE OR HEART PROTECTIVE AGENT
#41Cleavable lipids
#42CARBON QUANTUM DOT, A COMPOSITION THEREOF AND A METHOD FOR TREATING INFECTION BY USING SAME
#43SUBSTITUTED AMINO-THIOL AND AMINO-DISULFIDE COMPOUNDS, AND USES THEREOF
#44Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives
#45Compositions for controlled release of cysteamine and systemic treatment of cysteamine sensitive disorders
#46ADO-resistant cysteamine analogs and uses thereof
#47Lipids and compositions for the delivery of therapeutics
#48Compounds and methods for use in detecting gabapentin
#49COMPOUNDS FOR PROVIDING A LONG-LASTING STRAWBERRY ODOR
#50Multicomponent degradable cationic polymers
#51Vitamin cationic lipids
#52NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#53Potent and selective inhibitors of monoamine transporters; method of making; and use thereof
#54Ligand and method of manufacturing the same, quantum dot film and method of manufacturing the same, and display apparatus
#55Alkoxy compounds for disease treatment
#56Method of monomerisation of recombinant antibody molecules
#57Cationic lipid exhibiting improved intracellular dynamics
#58Method of synthesis of an ionizable cationic lipid
#59Compounds and methods for use in detecting gabapentin
#60Nucleic acid-containing lipid nanoparticle
#61Lipid containing formulations
#62MULTICOMPONENT DEGRADABLE CATIONIC POLYMERS
#63Substituted bicyclic compounds
#64Method for preparation of N-acetyl cysteine amide and derivatives thereof
#65Process for the preparation of freeze-dried 2-[(3-aminopropyl)amino] ethanethiol formulation
#66Cleavable lipids
#67Sulfide-based compounds and uses thereof
#68Compositions and methods for the treatment of xerostomia
#69Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives
#70Cleavable lipids
#71Phenolic resin composition and the use thereof in a rubber composition to reduce hysteresis
#72Compound exhibiting anti-oxidative or anti-inflammatory activity
#73Sulfide alkyl compounds for HBV treatment
#74Amino mercaptan compound and preparation method therefor and use thereof in protection against radiation
#75Potent and selective inhibitors of monoamine transporters; method of making; and use thereof
#76Alkoxy compounds for disease treatment
#77Lipids and compositions for the delivery of therapeutics
#78Dithioamine reducing agents
#79Compounds and Methods for Use in Detecting Gabapentin
#80Tetradentate ligand, and production method therefor, synthetic intermediate thereof, and transition metal complex thereof
#81Pharmaceutical compounds
#82Contact-killing, QAC functionalized thermoplastic polyurethane for catheter applications
#83Composition including benzene diamine derivative for preventing or treating degenerative brain diseases
#84Method for preparation of N-acetyl cysteine amide and derivatives thereof
#85Substituted bicyclic compounds
#86Compositions for controlled release of cysteamine and systemic treatment of cysteamine sensitive disorders
#87SMALL MOLECULES FOR IMMUNOGENIC TREATMENT OF CANCER
#88Thiol adducts for corrosion inhibition
#89COMPOSITIONS FOR NUCLEIC ACID DELIVERY
#90FLUOROUS COMPOUND, METHOD OF PREPARING FLUOROUS TAGGED PROTEIN, AND METHOD OF IMMOBILIZING PROTEIN
#91Thiol-formyl hemiacetal corrosion inhibitors
#92ANTIBIOTIC OLIGOPEPTIDE MIMETICS
#93Monosubstituted or polysubstituted amphiphilic hypocrellin derivative, and preparation method and application thereof
#94Industrial process for the preparation of (5S, 10S)-10-benzyl-16-methyl-11, 14, 18-trioxo-15, 17, 19-trioxa-2,7,8-trithia-12-azahenicosan-5-aminium(E)-3-carboxyacrylate salt
#95CHEMICAL SYNTHESIS
#96METHODS AND COMPOSITIONS FOR DELIVERY OF ACTIVE AGENTS
#97Method of synthesis of an ionizable cationic lipid
#98Process for preparation of cysteamine bitartrate
#99Multicomponent Degradable Cationic Polymers
#100Alkoxy compounds for disease treatment
#101Ionizable cationic lipid for RNA delivery
#102Cleavable lipids
#103THIOL-FORMYL HEMIACETAL CORROSION INHIBITORS
#104METHOD AND COMPOSITION FOR RETAINING NUTRIENTS IN SOIL AT PLANTING SITES
#105Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
#106Lipids and compositions for the delivery of therapeutics
#107Method of monomerisation of recombinant antibody molecules
#108Potent and selective inhibitors of monoamine transporters; method of making; and use thereof
#109Lipids and compositions for the delivery of therapeutics
#110LIPID CONTAINING FORMULATIONS
#111NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#112Lipids and compositions for the delivery of therapeutics
#113Polyfunctional sorbent materials
#114Cleavable Lipids
#115Substituted bicyclic compounds
#116Sulfide alkyl compounds for HBV treatment
#117Ionizable cationic lipid for RNA delivery
#118Pharmaceutical compounds
#119Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#120SYNTHESIS AND USE OF AMINO LIPIDS
#121Catalysis and Catalysts for Polymerization
#122Compounds and methods for use in detecting gabapentin
#123Ionizable cationic lipid for RNA delivery
#124Tetradentate organic ligand H-MN-16Bn containing long alkyl group, precursor thereof, and method for preparing the same
#125Ionizable cationic lipid for RNA delivery
#126Catalysts based on amino-sulfide ligands for hydrogenation and dehydrogenation processes
#127Alkoxy compounds for disease treatment
#128Substituted bicyclic compounds
#129ADO-resistant cysteamine analogs and uses thereof
#130Hydrocarbyl carboxybetaine and method for preventing hofmann elimination in alkaline environment
#131Polycationic amphiphiles as antimicrobial agents
#132Alkyl phenyl sulfide derivative and pest control agent
#133Lipids and compositions for the delivery of therapeutics
#134Glycoside compound, method for producing thioether, ether, method for producing ether, method for producing glycoside compound, method for producing nucleic acid
#135Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
#136Use of Cysteamine in Treating Infections caused by Yeasts/Moulds
#137Substituted bicyclic compounds
#138Potent and selective inhibitors of monoamine transporters; method of making; and use thereof
#139Hindered phenol compound, preparation thereof and use thereof as an antioxidant
#140Phenoxyalkylamine compound
#141Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#142Precursor for labeling therapeutic agent for liver cancer and method for manufacturing the same
#143DITHIOAMINE REDUCING AGENTS
#144Dichlorophenyl-imino compounds and compositions, and methods for the treatment of mucositis
#145Lipids and compositions for the delivery of therapeutics
#146Multicomponent degradable cationic polymers
#147Composition, synthesis, and use of a new class of isonitriles
#148Ionizable cationic lipid for RNA delivery
#149Alkoxy compounds for disease treatment
#150Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#151Method for obtaining novel derivatives of naphthalene for the in vivo diagnosis of Alzheimer's disease
#152Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#153Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#154Substituted 2-[2-(phenyl) ethylamino]alkaneamide derivatives and their use as sodium and/or calcium channel modulators
#155Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
#156Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
#157Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
#158Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
#159Ionizable cationic lipid for RNA delivery
#160Biodegradable computed tomography contrast agents
#161Alkyl phenyl sulfide derivative and pest control agent
#1626,7-Dihydro-5H-benzo[7]annulene derivatives, processes for their preparation, pharmaceutical products comprising them and their use for preparing medicaments
#163Fluorosurfactants having improved biodegradability
#164Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#165Compounds and methods for use in detecting gabapentin
#166Cationic lipid having improved intracellular kinetics
#167Amine derivative compounds for treating ophthalmic diseases and disorders
#168pH-sensitive compound, use, composition and treatment process using same
#169Cleavable lipids
#170Compositions and methods for cytoprotection
#171Lipid containing formulations
#172Synthesis and growth regulatory activity of a prototype member of a new family of aminothiol radioprotectors
#173SYNTHESIS AND GROWTH REGULATORY ACTIVITY OF A PROTOTYPE MEMBER OF A NEW FAMILY OF AMlNOTHIOL RADIOPROTECTORS
#174Therapeutic polyamine compositions and their synthesis
#175Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
#176Compositions for nucleic acid delivery
#177IMPLANT FOR TREATING OR PREVENTING AN ANEURYSM
#178TREATMENT OF MECP-2 ASSOCIATED DISORDERS
#179Diterpenoid derivatives endowed of biological properties
#180Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
#181Intermediates of sitagliptin and preparation process thereof
#182Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
#1836,7-DIHYDRO-5H-BENZO[7]ANNULENE DERIVATIVES, PROCESS FOR PREPARATION THEREOF, PHARMACEUTICAL PREPARATIONS COMPRISING THEM, AND THE USE THEREOF FOR PRODUCTION OF MEDICAMENTS
#184COPPER(I)-ION SELECTIVE FLUORESCENT PROBE, METHOD FOR PREPARING THE SAME, METHOD FOR DIAGNOSING MALIGNANT DISEASE AND DIAGNOSIS KIT USING THE PROBE
#185ROS-activated compounds as selective anti-cancer therapeutics
#186Dithioamine reducing agents
#187Alkoxy compounds for disease treatment
#188Benzoxazine-thiol adducts
#189ALLOSTERIC BINDING COMPOUNDS
#190Pyrrolysine analogs
#191Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#192Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#193Method for obtaining novel derivatives of naphthalene for the in vivo diagnosis of alzheimer's disease
#194Ionic liquids having uronium cations and a process for making same
#195Lysine Specific Demethylase-1 inhibitors and their use
#196Alkoxy compounds for disease treatment
#197Alkoxy compounds for disease treatment
#198Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#199Multicomponent degradable cationic polymers
#200Alkoxy compounds for disease treatment
#201COMPOUND INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICINE CONTAINING THE SAME
#202NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#203ALLOSTERIC BINDING COMPOUNDS
#204Lipid containing formulations
#205Amine derivative compounds for treating ophthalmic diseases and disorders
#206Amine derivative compounds for treating ophthalmic diseases and disorders
#207Lipids and compositions for the delivery of therapeutics
#208Selective estrogen receptor modulator
#209Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#210Lipids and compositions for the delivery of therapeutics
#211Lipids and compositions for the delivery of therapeutics
#212Prodrugs containing novel bio-cleavable linkers
#213Prodrugs containing novel bio-cleavable linkers
#214Prodrugs containing novel bio-cleavable linkers
#215CYCLOHEXYLAMINE DERIVATIVE CONTAINING PHENYL GROUP, AND THERAPEUTIC AGENT FOR DISEASES ACCOMPANIED BY CENTRAL NERVOUS SYSTEM DISORDERS
#216NITRIC OXIDE RELEASING AMINO ACID ESTER COMPOUND, COMPOSITION AND METHOD OF USE
#217Antibacterial agents
#218Acylsulfonamides and processes for producing the same
#219Compounds as antagonists or inverse agonists at opioid receptors
#220Compositions and methods for the treatment of infectious diseases
#221Methods of chemotype evolution
#222COMPOSITIONS AND METHODS FOR THE DELIVERY OF NUCLEIC ACIDS
#223Reversible room-temperature ionic liquids
#224Antibacterial agents
#225Benzoxazine-thiol adducts
#226Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors
#227Biaryl carboxylic acid apoptosis promoters
#228Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
#229Methods and compositions for treating amyloid-related diseases
#230Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives
#231Apoptosis promoters
#232NON-IMIDAZOLE ARYLOXYALKYLAMINES
#233Alkoxy compounds for disease treatment
#234Selective estrogen receptor modulator
#235Amine derivative compounds for treating ophthalmic diseases and disorders
#236Substituted hydroxyethylamine aspartyl protease inhibitors
#237Antibacterial agents
#238Method for generating metal chelating affinity ligands
#239Histone deacetylase inhibitors
#240Calcium receptor active compounds
#241Adamantane derivatives
#242Styrenyl Derivative Compounds for Treating Ophthalmic Diseases and Disorders
#243Antibacterial agents
#244Functionalized monomers and functionalized rubbery polymers made therewith
#245Benzylamine analogues
#246Sulfur containing fluoroalkyl amines and isocyanates
#247CLASS OF ORGANIC COMPOUNDS CONTAINING HETEROATOM AND ITS APPLICATIONS IN PREPARING SINGLE-SITE ZIEGLER-NATTA CATALYST
#248Room temperature molten salt and display element
#249Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#250Compositions and methods for cytoprotection
#251Lipid containing formulations
#252NON-IMIDAZOLE ARYLOXYALKYLAMINES
#253Antibacterial agents
#254Benzonitryl and nitrobenzyl derivatives that modulate androgen receptors
#255Benzylamine analogues
#256Compound, a molecular switch employing the compound and a method of electronic switching
#257Thyroid Receptor Agonists
#258Compounds and Methods for the Inhibition of the Expression of VCAM-1
#259Trimerisation and oligomerisation of olefins using a chromium based catalyst
#260Compounds and methods for use in detecting gabapentin
#261Adamantane derivatives
#262Processes and intermediates preparing cysteine protease inhibitors
#263Stilbene derivatives and their use for binding and imaging amyloid plaques
#264Tricyclic aromatic and bis-phenyl sulfinyl derivatives
#265Androgen Receptor Modulators
#266Ionic liquids having uronium or thiouronium cations
#267CALCILYTIC COMPOUNDS
#268Antibacterial agents
#269Mercaptophenyl naphthyl methane compounds and synthesis thereof
#270POLYAMINES USEFUL AS ANTI-PARASITIC AND ANTI-CANCER THERAPEUTICS AND AS LYSINE-SPECIFIC DEMETHYLASE INHIBITORS
#271Cathepsin cysteine protease inhibitors
#272Apoptosis promoters
#273Adamantane derivatives
#274Indane derivates as muscarinic receptor agonists
#275Benzylamine analogues
#276Benzylamine analogues
#277Sulfoxides or sulfones grafted onto polymers
#278Novel double para-phenylenediamines joined by a linkage comprising an atom chosen from sulphur and nitrogen and method for dyeing keratinous fibers
#279Methods and compositions for treating amyloid-related diseases
#280Non-imidazole aryloxyalkylamines
#281Compound inhibiting in vivo phosphorous transport and medicine containing the same
#282Prodrugs containing novel bio-cleavable linkers
#283Compounds and methods for treating transplant rejection
#284Methods and fluorinated compositions for treating amyloid-related diseases
#285Small technetium-99m and rhenium labeled agents and methods for imaging tissues, organs and tumors
#286Antibacterial agents
#287Chemical compounds
#288Selective estrogen receptor modulator
#289Aryl-quinazoline/aryl-2-amino-phenyl methanone derivatives
#290Chemical compounds
#291Compound, a molecular switch employing the compound and a method of electronic switching
#292Prodrugs containing novel bio-cleavable linkers
#293Polythiaether compounds and their use as corrosion inhibitors
#294Anti tubercular drug: compositions and methods
#295Sulfur-containing secondary para-phenylenediamines dye compositions comprising such para-phenylenediamines, processes, and uses thereof
#296Stilbene derivatives and their use for binding and imaging amyloid plaques
#297Agents for imaging and diagnostic methods using them
#298Biphenyls and fluorenes as imaging agents in alzheimer's disease
#299Intermediates useful in the synthesis of HIV-protease inhibitors and methods for preparing the same
#300Inhibitors of bacterial type III protein secretion systems